Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | Healthcare | 539,704.0 | $45.8M | 6.18% | NEW | — | $84.90 | +32.6% |
| 2 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 369,996.0 | $37.4M | 5.04% | NEW | — | $100.99 | -13.0% |
| 3 | — | AVIDITY BIOSCIENCES INC | — | 844,633.0 | $36.8M | 4.96% | NEW | — | $43.57 | — |
| 4 | NUVL | NUVALENT INC | Healthcare | 372,300.0 | $32.2M | 4.34% | NEW | — | $86.48 | +15.8% |
| 5 | URGN | UROGEN PHARMA LTD | Healthcare | 1,577,283.0 | $31.5M | 4.24% | NEW | — | $19.95 | +44.8% |
| 6 | — | AKERO THERAPEUTICS INC | — | 643,636.0 | $30.6M | 4.12% | NEW | — | $47.48 | — |
| 7 | INSM | INSMED INC | Healthcare | 206,648.0 | $29.8M | 4.01% | NEW | — | $144.01 | -26.5% |
| 8 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 674,966.0 | $26.6M | 3.58% | NEW | — | $39.35 | +109.3% |
| 9 | QURE | UNIQURE NV | Healthcare | 455,000.0 | $26.6M | 3.58% | NEW | — | $58.37 | -57.4% |
| 10 | CGON | CG ONCOLOGY INC | Healthcare | 638,346.0 | $25.7M | 3.47% | NEW | — | $40.28 | +59.7% |
| 11 | — PUT | UNITED THERAPEUTICS CORP DEL | — | 59,900.0 | $25.1M | 3.39% | NEW | — | $419.21 | — |
| 12 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 1,948,808.0 | $23.4M | 3.15% | NEW | — | $12.00 | -34.3% |
| 13 | — | CIDARA THERAPEUTICS INC | — | 220,902.0 | $21.2M | 2.85% | NEW | — | $95.76 | — |
| 14 | GUTS | FRACTYL HEALTH INC | Healthcare | 10,600,000.0 | $16.9M | 2.27% | NEW | — | $1.59 | -51.0% |
| 15 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 1,363,378.0 | $16.6M | 2.24% | NEW | — | $12.18 | +119.5% |
| 16 | KOD | KODIAK SCIENCES INC | Healthcare | 1,000,000.0 | $16.4M | 2.21% | NEW | — | $16.37 | +114.4% |
| 17 | — CALL | ULTRAGENYX PHARMACEUTICAL IN | — | 528,200.0 | $15.9M | 2.14% | NEW | — | $30.08 | — |
| 18 | GOSS | GOSSAMER BIO INC | Healthcare | 4,779,082.0 | $12.6M | 1.70% | NEW | — | $2.63 | -91.7% |
| 19 | COGT | COGENT BIOSCIENCES INC | Healthcare | 815,075.0 | $11.7M | 1.58% | NEW | — | $14.36 | +121.1% |
| 20 | CYTK | CYTOKINETICS INC | Healthcare | 211,000.0 | $11.6M | 1.56% | NEW | — | $54.96 | +38.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%